DME competitive bidding momentum
This article was originally published in The Gray Sheet
Executive Summary
One-year freeze on durable medical equipment spending, followed by competitive bidding implementation, likely will be included in the final Medicare reform package, according to device stakeholders. The new technology provisions also are coming under scrutiny, as conferees look to keep the "Medicare Prescription Drug & Modernization Act" of 2003 (HR 1, S 1) under the $400 bil. figure proposed by President Bush. Working with lawmakers, AdvaMed has succeeded in reducing the new tech score to $1.5 bil., but conferees may try to lower the amount to $1 bil. or less...
You may also be interested in...
Medicare Reform Prospects Beginning To Fade – CMS Administrator Scully
CMS Administrator Tom Scully is no longer confident that the Medicare reform conference committee will be able to agree on a final product, let alone produce a bill that can pass both chambers
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.